NALOXONE HCl
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
51662-1620 -
Package NDC
51662-1620-1 -
Package NDC
51662-1620-2 -
Application number
ANDA211951 -
SPL ID
100bc933-5bf3-8de2-e063-6294a90a7ba6 -
SPL set ID
f8fcda15-8ba6-e66a-e053-6294a90a385c -
UNII
F850569PQR -
RxCUI
1725059
What the source publishes
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Active ingredients
- NALOXONE HCl
- Form
- SPRAY
- Routes
- NASAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "NALOXONE HCl",
"splId": "100bc933-5bf3-8de2-e063-6294a90a7ba6",
"labels": [
{
"setId": "f8fcda15-8ba6-e66a-e053-6294a90a385c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f8fcda15-8ba6-e66a-e053-6294a90a385c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f8fcda15-8ba6-e66a-e053-6294a90a385c"
}
],
"routes": [
"NASAL"
],
"labeler": "HF Acquisition Co LLC, DBA HealthFirst",
"finished": true,
"packaging": [
{
"sample": false,
"description": ".1 mL in 1 VIAL, SINGLE-DOSE (51662-1620-1)",
"package_ndc": "51662-1620-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20230410"
},
{
"sample": false,
"description": "2 VIAL, SINGLE-DOSE in 1 CARTON (51662-1620-2) / .1 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "51662-1620-2",
"identifierStatus": "well-formed",
"marketing_start_date": "20230410"
}
],
"productId": "51662-1620_100bc933-5bf3-8de2-e063-6294a90a7ba6",
"useDomain": "unknown",
"dosageForm": "SPRAY",
"productNdc": "51662-1620",
"deaSchedule": null,
"genericName": "NALOXONE HCl",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NALOXONE HYDROCHLORIDE",
"strength": "4 mg/.1mL"
}
],
"applicationNumber": "ANDA211951",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230410",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0345802811004"
],
"unii": [
"F850569PQR"
],
"rxcui": [
"1725059"
],
"spl_set_id": [
"f8fcda15-8ba6-e66a-e053-6294a90a385c"
],
"manufacturer_name": [
"HF Acquisition Co LLC, DBA HealthFirst"
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:51662-1620_100bc933-5bf3-8de2-e063-6294a90a7ba6"